PRL PTPs: Mediators and markers of cancer progression

Cancer and Metastasis Reviews

Volumn 27, Issue 2, 2008, Pages 231-252

  Bessette, Darrell C ^a,b   Qiu, Dexin ^a,b   Pallen, Catherine J ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cancer; Epithelial mesenchymal transition; Invasion; Metastasis; Migration; PRL 1; PRL 2; PRL 3; Protein tyrosine phosphatase; Signaling

Indexed keywords

BIOLOGICAL MARKER; ENZYME INHIBITOR; FLAVONOID; GERANYLGERANYLTRANSFERASE INHIBITOR; GINKGETIN; PENTAMIDINE; PHOSPHATASE OF REGENERATING LIVER 1; PHOSPHATASE OF REGENERATING LIVER 2; PHOSPHATASE OF REGENERATING LIVER 3; PROTEIN TYROSINE PHOSPHATASE; RHODANINE; SCIADOPITYSIN; TUMOR MARKER;

ANGIOGENESIS; BREAST CANCER; CANCER GROWTH; CARCINOGENESIS; CELL ADHESION; CELL CYCLE REGULATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; COLORECTAL CANCER; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SUBSTRATE; EPITHELIUM; HUMAN; LOW DRUG DOSE; MEDIATOR; MESENCHYME; METASTASIS; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVIEW; STOMACH CANCER; UPREGULATION;

ANIMALS; DISEASE PROGRESSION; HUMANS; NEOPLASMS; NEOPLASTIC PROCESSES; PROTEIN TYROSINE PHOSPHATASES;

EID: 43049131055     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-008-9121-3     Document Type: Review

References (109)

1. Mohn, K. L., Laz, T. M., Hsu, J. C., Melby, A. E., Bravo, R., & Taub, R. (1991). The immediate-early growth response in regenerating liver and insulin-stimulated H-35 cells: comparison with serum-stimulated 3T3 cells and identification of 41 novel immediate-early genes. Molecular and Cellular Biology, 11, 381-390.
2. Diamond, R. H., Cressman, D. E., Laz, T. M., Abrams, C. S., & Taub, R. (1994). PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth. Molecular and Cellular Biology, 14, 3752-3762.
3. Montagna, M., Serova, O., Sylla, B. S., Feunteun, J., & Lenoir, G. M. (1995). A 100-kb physical and transcriptional map around the EDH17B2 gene: identification of three novel genes and a pseudogene of a human homologue of the rat PRL-1 tyrosine phosphatase. Human Genetics, 96, 532-538.
4. Cates, C. A., Michael, R. L., Stayrook, K. R., Harvey, K. A., Burke, Y. D., Randall, S. K., et al. (1996). Prenylation of oncogenic human PTP(CAAX) protein tyrosine phosphatases. Cancer Letters, 110, 49-55.
5. Zeng, Q., Hong, W., & Tan, Y. H. (1998). Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1. Biochemical and Biophysical Research Communications, 244, 421-427.
6. Zeng, Q., Si, X., Horstmann, H., Xu, Y., Hong, W., & Pallen, C. J. (2000). Prenylation-dependent association of protein-tyrosine phosphatases PRL-1, -2, and -3 with the plasma membrane and the early endosome. Journal of Biological Chemistry, 275, 21444-21452.
7. Sun, J. P., Wang, W. Q., Yang, H., Liu, S., Liang, F., Fedorov, A. A., et al. (2005). Structure and biochemical properties of PRL-1, a phosphatase implicated in cell growth, differentiation, and tumor invasion. Biochemistry, 44, 12009-12021.
8. Jeong, D. G., Kim, S. J., Kim, J. H., Son, J. H., Park, M. R., Lim, S. M., et al. (2005). Trimeric structure of PRL-1 phosphatase reveals an active enzyme conformation and regulation mechanisms. Journal of Molecular Biology, 345, 401-413.
9. Kim, K. A., Song, J. S., Jee, J., Sheen, M. R., Lee, C., Lee, T. G., et al. (2004). Structure of human PRL-3, the phosphatase associated with cancer metastasis. FEBS Letters, 565, 181-187.
10. Kozlov, G., Cheng, J., Ziomek, E., Banville, D., Gehring, K., & Ekiel, I. (2004). Structural insights into molecular function of the metastasis-associated phosphatase PRL-3. Journal of Biological Chemistry, 279, 11882-11889.
11. Zhou, H., Gallina, M., Mao, H., Nietlispach, D., Betz, S. F., Fetrow, J. S., et al. (2003). 1H, 13C and 15N resonance assignments and secondary structure of the human protein tyrosine phosphatase, PRL-2. Journal of Biomolecular NMR, 27, 397-398.
12. Barford, D., Das, A. K., & Egloff, M. P. (1998). The structure and mechanism of protein phosphatases: Insights into catalysis and regulation. Annual Review of Biophysics and Biomolecular Structure, 27, 133-164.
13. Denu, J. M., Stuckey, J. A., Saper, M. A., & Dixon, J. E. (1996). Form and function in protein dephosphorylation. Cell, 87, 361-364.
14. Zhang, Z. Y. (1998). Protein-tyrosine phosphatases: Biological function, structural characteristics, and mechanism of catalysis. Critical Reviews in Biochemistry and Molecular Biology, 33, 1-52.
15. Wang, J., Kirby, C. E., & Herbst, R. (2002). The tyrosine phosphatase PRL-1 localizes to the endoplasmic reticulum and the mitotic spindle and is required for normal mitosis. Journal of Biological Chemistry, 277, 46659-46668.
16. Zhang, Z. Y., Palfey, B. A., Wu, L., & Zhao, Y. (1995). Catalytic function of the conserved hydroxyl group in the protein tyrosine phosphatase signature motif. Biochemistry, 34, 16389-16396.
17. Denu, J. M., & Dixon, J. E. (1995). A catalytic mechanism for the dual-specific phosphatases. Proceedings of the National Academy of Sciences of the United States of America, 92, 5910-5914.
18. Sun, J. P., Luo, Y., Yu, X., Wang, W. Q., Zhou, B., Liang, F., et al. (2007). Phosphatase activity, trimerization, and the C-terminal polybasic region are all required for PRL1-mediated cell growth and migration. Journal of Biological Chemistry, 282, 29043-29051.
19. Yu, L., Kelly, U., Ebright, J. N., Malek, G., Saloupis, P., Rickman, D. W., et al. (2007). Oxidative stress-induced expression and modulation of Phosphatase of Regenerating Liver-1 (PRL-1) in mammalian retina. Biochimica et Biophysica Acta, 1773, 1473-1482.
20. Dumaual, C. M., Sandusky, G. E., Crowell, P. L., & Randall, S. K. (2006). Cellular localization of PRL-1 and PRL-2 gene expression in normal adult human tissues. Journal of Histochemistry and Cytochemistry, 54, 1401-1412.
21. Matter, W. F., Estridge, T., Zhang, C., Belagaje, R., Stancato, L., Dixon, J., et al. (2001). Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling. Biochemical and Biophysical Research Communications, 283, 1061-1068.
22. Wang, Q., Holmes, D. I., Powell, S. M., Lu, Q. L., & Waxman, J. (2002). Analysis of stromal-epithelial interactions in prostate cancer identifies PTPCAAX2 as a potential oncogene. Cancer Letters, 175, 63-69.
23. Kato, H., Semba, S., Miskad, U. A., Seo, Y., Kasuga, M., & Yokozaki, H. (2004). High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: A predictive molecular marker of metachronous liver and lung metastases. Clinical Cancer Research, 10, 7318-7328.
24. Miskad, U. A., Semba, S., Kato, H., & Yokozaki, H. (2004). Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis. Pathobiology, 71, 176-184.
25. Rouleau, C., Roy, A., St Martin, T., Dufault, M. R., Boutin, P., Liu, D., et al. (2006). Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function. Molecular Cancer Therapeutics, 5, 219-229.
26. Radke, I., Gotte, M., Kersting, C., Mattsson, B., Kiesel, L., & Wulfing, P. (2006). Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer. British Journal of Cancer, 95, 347-354.
27. Si, X., Zeng, Q., Ng, C. H., Hong, W., & Pallen, C. J. (2001). Interaction of farnesylated PRL-2, a protein-tyrosine phosphatase, with the beta-subunit of geranylgeranyltransferase II. Journal of Biological Chemistry, 276, 32875-32882.
28. Fiordalisi, J. J., Keller, P. J., & Cox, A. D. (2006). PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. Cancer Research, 66, 3153-3161.
29. Diamond, R. H., Peters, C., Jung, S. P., Greenbaum, L. E., Haber, B. A., Silberg, D. G., et al. (1996). Expression of PRL-1 nuclear PTPase is associated with proliferation in liver but with differentiation in intestine. American Journal of Physiology, 271, G121-129.
30. Kong, W., Swain, G. P., Li, S., & Diamond, R. H. (2000). PRL-1 PTPase expression is developmentally regulated with tissue-specific patterns in epithelial tissues. American Journal of Physiology -l Gastrointestinal and Liver Physiology, 279, G613-G621.
31. Yarovinsky, T. O., Rickman, D. W., Diamond, R. H., Taub, R., Hageman, G. S., & Bowes Rickman, C. (2000). Expression of the protein tyrosine phosphatase, phosphatase of regenerating liver 1, in the outer segments of primate cone photoreceptors. Brain Research. Molecular Brain Research, 77, 95-103.
32. Saha, S., Bardelli, A., Buckhaults, P., Velculescu, V. E., Rago, C., St Croix, B., et al. (2001). A phosphatase associated with metastasis of colorectal cancer. Science, 294, 1343-1346.
33. Bardelli, A., Saha, S., Sager, J. A., Romans, K. E., Xin, B., Markowitz, S. D., et al. (2003). PRL-3 expression in metastatic cancers. Clinical Cancer Research, 9, 5607-5615.
34. Li, J., Guo, K., Koh, V. W., Tang, J. P., Gan, B. Q., Shi, H., et al. (2005). Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases. Clinical Cancer Research, 11, 2195-2204.
35. Peng, L., Ning, J., Meng, L., & Shou, C. (2004). The association of the expression level of protein tyrosine phosphatase PRL-3 protein with liver metastasis and prognosis of patients with colorectal cancer. Journal of Cancer Research and Clinical Oncology, 130, 521-526.
36. Wang, Y., Li, Z. F., He, J., Li, Y. L., Zhu, G. B., & Zhang, L. H. (2007). Expression of the human phosphatases of regenerating liver (PRLs) in colonic adenocarcinoma and its correlation with lymph node metastasis. International Journal of Colorectal Disease, 22, 1179-1184.
37. Wang, L., Peng, L., Dong, B., Kong, L., Meng, L., Yan, L., et al. (2006). Overexpression of phosphatase of regenerating liver-3 in breast cancer: Association with a poor clinical outcome. Annals of Oncology, 17, 1517-1522.
38. Miskad, U. A., Semba, S., Kato, H., Matsukawa, Y., Kodama, Y., Mizuuchi, E., et al. (2007). High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: An in situ hybridization study. Virchows Archiv, 450, 303-310.
39. Li, Z. R., Wang, Z., Zhu, B. H., He, Y. L., Peng, J. S., Cai, S. R., et al. (2007). Association of tyrosine PRL-3 phosphatase protein expression with peritoneal metastasis of gastric carcinoma and prognosis. Surgery Today, 37, 646-651.
40. Wu, X., Zeng, H., Zhang, X., Zhao, Y., Sha, H., Ge, X., et al. (2004). Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells. American Journal of Pathology, 164, 2039-2054.
41. Polato, F., Codegoni, A., Fruscio, R., Perego, P., Mangioni, C., Saha, S., et al. (2005). PRL-3 phosphatase is implicated in ovarian cancer growth. Clinical Cancer Research, 11, 6835-6839.
42. Yamashita, S., Masuda, Y., Matsumoto, K., Okumura, Y., Matsuzaki, H., Kurizaki, T., et al. (2007). Down-regulation of the human PRL-3 gene is associated with the metastasis of primary non-small cell lung cancer. Annals of Thoracic and Cardiovascular Surgery, 13, 236-239.
43. Zeng, Q., Dong, J. M., Guo, K., Li, J., Tan, H. X., Koh, V., et al. (2003). PRL-3 and PRL-1 promote cell migration, invasion, and metastasis. Cancer Research, 63, 2716-2722.
44. Guo, K., Li, J., Tang, J. P., Koh, V., Gan, B. Q., & Zeng, Q. (2004). Catalytic domain of PRL-3 plays an essential role in tumor metastasis: Formation of PRL-3 tumors inside the blood vessels. Cancer Biology & Therapy, 3, 945-951.
45. Qian, F., Li, Y. P., Sheng, X., Zhang, Z. C., Song, R., Dong, W., et al. (2007). PRL-3 siRNA inhibits the metastasis of B16-BL6 mouse melanoma cells in vitro and in vivo. Molecular Medicine, 13, 151-159.
46. Li, Z., Zhan, W., Wang, Z., Zhu, B., He, Y., Peng, J., et al. (2006). Inhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via microRNA suppressed reduces peritoneal metastasis. Biochemical and Biophysical Research Communications, 348, 229-237.
47. St Croix, B., Rago, C., Velculescu, V., Traverso, G., Romans, K. E., Montgomery, E., et al. (2000). Genes expressed in human tumor endothelium. Science, 289, 1197-1202.
48. Guo, K., Li, J., Wang, H., Osato, M., Tang, J. P., Quah, S. Y., et al. (2006). PRL-3 initiates tumor angiogenesis by recruiting endothelial cells in vitro and in vivo. Cancer Research, 66, 9625-9635.
49. Wang, H., Quah, S. Y., Dong, J. M., Manser, E., Tang, J. P., & Zeng, Q. (2007). PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition. Cancer Research, 67, 2922-2926.
50. Nicholson, K. M., & Anderson, N. G. (2002). The protein kinase B/Akt signalling pathway in human malignancy. Cellular Signalling, 14, 381-395.
51. Dillon, R. L., White, D. E., & Muller, W. J. (2007). The phosphatidyl inositol 3-kinase signaling network: Implications for human breast cancer. Oncogene, 26, 1338-1345.
52. Altomare, D. A., & Testa, J. R. (2005). Perturbations of the AKT signaling pathway in human cancer. Oncogene, 24, 7455-7464.
53. Larue, L., & Bellacosa, A. (2005). Epithelial-mesenchymal transition in development and cancer: Role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene, 24, 7443-7454.
54. Thiery, J. P., & Sleeman, J. P. (2006). Complex networks orchestrate epithelial-mesenchymal transitions. Nature Reviews Molecular Cell Biology, 7, 131-142.
55. Guarino, M., Rubino, B., & Ballabio, G. (2007). The role of epithelial-mesenchymal transition in cancer pathology. Pathology, 39, 305-318.
56. Barbera, M. J., Puig, I., Dominguez, D., Julien-Grille, S., Guaita-Esteruelas, S., Peiro, S., et al. (2004). Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells. Oncogene, 23, 7345-7354.
57. Zhou, B. P., Deng, J., Xia, W., Xu, J., Li, Y. M., Gunduz, M., et al. (2004). Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nature Cell Biology, 6, 931-940.
58. Julien, S., Puig, I., Caretti, E., Bonaventure, J., Nelles, L., van Roy, F., et al. (2007). Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene, 26, 7445-7456.
59. Li, Z., Wang, L., Zhang, W., Fu, Y., Zhao, H., Hu, Y., et al. (2007). Restoring E-cadherin-mediated cell-cell adhesion increases PTEN protein level and stability in human breast carcinoma cells. Biochemical and Biophysical Research Communications, 363, 165-170.
60. Watabe-Uchida, M., Uchida, N., Imamura, Y., Nagafuchi, A., Fujimoto, K., Uemura, T., et al. (1998). Alpha-Catenin-vinculin interaction functions to organize the apical junctional complex in epithelial cells. Journal of Cell Biology, 142, 847-857.
61. Kawajiri, A., Itoh, N., Fukata, M., Nakagawa, M., Yamaga, M., Iwamatsu, A., et al. (2000). Identification of a novel beta-catenin-interacting protein. Biochemical and Biophysical Research Communications, 273, 712-717.
62. Subauste, M. C., Nalbant, P., Adamson, E. D., & Hahn, K. M. (2005). Vinculin controls PTEN protein level by maintaining the interaction of the adherens junction protein beta-catenin with the scaffolding protein MAGI-2. Journal of Biological Chemistry, 280, 5676-5681.
63. Hehlgans, S., Haase, M., & Cordes, N. (2007). Signalling via integrins: Implications for cell survival and anticancer strategies. Biochimica et Biophysica Acta, 1775, 163-180.
64. Mitra, S. K., & Schlaepfer, D. D. (2006). Integrin-regulated FAK-Src signaling in normal and cancer cells. Current Opinion in Cell Biology, 18, 516-523.
65. Peng, L., Jin, G., Wang, L., Guo, J., Meng, L., & Shou, C. (2006). Identification of integrin alpha1 as an interacting protein of protein tyrosine phosphatase PRL-3. Biochemical and Biophysical Research Communications, 342, 179-183.
66. Liang, F., Liang, J., Wang, W. Q., Sun, J. P., Udho, E., & Zhang, Z. Y. (2007). PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation. Journal of Biological Chemistry, 282, 5413-5419.
67. Okada, M., Nada, S., Yamanashi, Y., Yamamoto, T., & Nakagawa, H. (1991). CSK: A protein-tyrosine kinase involved in regulation of src family kinases. Journal of Biological Chemistry, 266, 24249-24252.
68. Kunte, D. P., Wali, R. K., Koetsier, J. L., Hart, J., Kostjukova, M. N., Kilimnik, A. Y., et al. (2005). Down-regulation of the tumor suppressor gene C-terminal Src kinase: an early event during premalignant colonic epithelial hyperproliferation. FEBS Letters, 579, 3497-3502.
69. Defilippi, P., Di Stefano, P., & Cabodi, S. (2006). p130Cas: A versatile scaffold in signaling networks. Trends in Cell Biology, 16, 257-263.
70. Achiwa, H., & Lazo, J. S. (2007). PRL-1 tyrosine phosphatase regulates c-Src levels, adherence, and invasion in human lung cancer cells. Cancer Research, 67, 643-650.
71. Shah, A. N., & Gallick, G. E. (2007). Src, chemoresistance and epithelial to mesenchymal transition: are they related? Anti-Cancer Drugs, 18, 371-375.
72. Cheng, J. Q., Lindsley, C. W., Cheng, G. Z., Yang, H., & Nicosia, S. V. (2005). The Akt/PKB pathway: molecular target for cancer drug discovery. Oncogene, 24, 7482-7492.
73. Avizienyte, E., & Frame, M. C. (2005). Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition. Current Opinion in Cell Biology, 17, 542-547.
74. Werner, S. R., Lee, P. A., DeCamp, M. W., Crowell, D. N., Randall, S. K., & Crowell, P. L. (2003). Enhanced cell cycle progression and down regulation of p21(Cip1/Waf1) by PRL tyrosine phosphatases. Cancer Letters, 202, 201-211.
75. Gnainsky, Y., Spira, G., Paizi, M., Bruck, R., Nagler, A., Genina, O., et al. (2006). Involvement of the tyrosine phosphatase early gene of liver regeneration (PRL-1) in cell cycle and in liver regeneration and fibrosis effect of halofuginone. Cell and Tissue Research, 324, 385-394.
76. Kadambi, V. J., Lorenz, J. N., Stagliano, N. E., Matter, W. F., Wang, X. S., Bloem, L., et al. (2000). Impaired ventricular relaxation resulting from cardiac-specific overexpression of a human prenylated protein tyrosine phosphatase. Circulation (Suppl), 102, II-268.
77. Chinnaiyan, K. M., Alexander, D., & McCullough, P. A. (2005). Role of angiotensin II in the evolution of diastolic heart failure. Journal of Clinical Hypertension (Greenwich), 7, 740-747.
78. Ehrlich, J. R., Hohnloser, S. H., & Nattel, S. (2006). Role of angiotensin system and effects of its inhibition in atrial fibrillation: Clinical and experimental evidence. European Heart Journal, 27, 512-518.
79. Peters, C. S., Liang, X., Li, S., Kannan, S., Peng, Y., Taub, R., et al. (2001). ATF-7, a novel bZIP protein, interacts with the PRL-1 protein-tyrosine phosphatase. Journal of Biological Chemistry, 276, 13718-13726.
80. Monaco, S. E., Angelastro, J. M., Szabolcs, M., & Greene, L. A. (2007). The transcription factor ATF5 is widely expressed in carcinomas, and interference with its function selectively kills neoplastic, but not nontransformed, breast cell lines. International Journal of Cancer, 120, 1883-1890.
81. Zerial, M., & McBride, H. (2001). Rab proteins as membrane organizers. Nature Reviews Molecular Cell Biology, 2, 107-117.
82. Magnusson, C., Svensson, A., Christerson, U., & Tagerud, S. (2005). Denervation-induced alterations in gene expression in mouse skeletal muscle. European Journal of Neuroscience, 21, 577-580.
83. Yuan, L., Chen, J., Lin, B., Zhang, J., & Zhang, S. (2007). Differential expression and functional constraint of PRL-2 in hibernating bat. Comparative Biochemistry and Physiology. Part B, Biochemistry and Molecular Biology, 148, 375-381.
84. Peng, Y., Du, K., Ramirez, S., Diamond, R. H., & Taub, R. (1999). Mitogenic up-regulation of the PRL-1 protein-tyrosine phosphatase gene by Egr-1. Egr-1 activation is an early event in liver regeneration. Journal of Biological Chemistry, 274, 4513-4520.
85. Peng, Y., Genin, A., Spinner, N. B., Diamond, R. H., & Taub, R. (1998). The gene encoding human nuclear protein tyrosine phosphatase, PRL-1. Cloning, chromosomal localization, and identification of an intron enhancer. Journal of Biological Chemistry, 273, 17286-17295.
86. Gregory, R. C., Lord, K. A., Panek, L. B., Gaines, P., Dillon, S. B., & Wojchowski, D. M. (2000). Subtraction cloning and initial characterization of novel epo-immediate response genes. Cytokine, 12, 845-857.
87. McLean, D. J., Friel, P. J., Pouchnik, D., & Griswold, M. D. (2002). Oligonucleotide microarray analysis of gene expression in follicle-stimulating hormone-treated rat Sertoli cells. Molecular Endocrinology, 16, 2780-2792.
88. Schmidt, J., de Avila, J., & McLean, D. (2006). Regulation of protein tyrosine phosphatase 4a1, B-cell translocation gene 2, nuclear receptor subfamily 4a1 and diacylglycerol O-acyltransferase 1 by follicle stimulating hormone in the rat ovary. Reproduction, Fertility, and Development, 18, 757-765.
89. Scarlato, M., Beesley, J., & Pleasure, D. (2000). Analysis of oligodendroglial differentiation using cDNA arrays. Journal of Neuroscience Research, 59, 430-435.
90. Takano, S., Fukuyama, H., Fukumoto, M., Kimura, J., Xue, J. H., Ohashi, H., et al. (1996). PRL-1, a protein tyrosine phosphatase, is expressed in neurons and oligodendrocytes in the brain and induced in the cerebral cortex following transient forebrain ischemia. Brain Research. Molecular Brain Research, 40, 105-115.
91. Grimes, J. A., Fraser, S. P., Stephens, G. J., Downing, J. E., Laniado, M. E., Foster, C. S., et al. (1995). Differential expression of voltage-activated Na+ currents in two prostatic tumour cell lines: Contribution to invasiveness in vitro. FEBS Letters, 369, 290-294.
92. Fraser, S. P., Salvador, V., Manning, E. A., Mizal, J., Altun, S., Raza, M., et al. (2003). Contribution of functional voltage-gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: I. Lateral motility. Journal of Cellular Physiology, 195, 479-487.
93. Raghavendra Prasad, H. S., Qi, Z., Srinivasan, K. N., & Gopalakrishnakone, P. (2004). Potential effects of tetrodotoxin exposure to human glial cells postulated using microarray approach. Toxicon, 44, 597-608.
94. Tonks, N. K. (2005). Redox redux: Revisiting PTPs and the control of cell signaling. Cell, 121, 667-670.
95. den Hertog, J., Groen, A., & van der Wijk, T. (2005). Redox regulation of protein-tyrosine phosphatases. Archives of Biochemistry and Biophysics, 434, 11-15.
96. Ahn, J. H., Kim, S. J., Park, W. S., Cho, S. Y., Ha, J. D., Kim, S. S., et al. (2006). Synthesis and biological evaluation of rhodanine derivatives as PRL-3 inhibitors. Bioorganic and Medicinal Chemistry Letters, 16, 2996-2999.
97. Choi, S. K., Oh, H. M., Lee, S. K., Jeong, D. G., Ryu, S. E., Son, K. H., et al. (2006). Biflavonoids inhibited phosphatase of regenerating liver-3 (PRL-3). Natural Product Research, 20, 341-346.
98. Dursina, B., Reents, R., Delon, C., Wu, Y., Kulharia, M., Thutewohl, M., et al. (2006). Identification and specificity profiling of protein prenyltransferase inhibitors using new fluorescent phosphoisoprenoids. Journal of the American Chemical Society, 128, 2822-2835.
99. Pathak, M. K., Dhawan, D., Lindner, D. J., Borden, E. C., Farver, C., & Yi, T. (2002). Pentamidine is an inhibitor of PRL phosphatases with anticancer activity. Molecular Cancer Therapeutics, 1, 1255-1264.
100. Sands, M., Kron, M. A., & Brown, R. B. (1985). Pentamidine: A review. Reviews of Infectious Diseases, 7, 625-634.
101. Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P., & McPhail, A. T. (1971). Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. Journal of the American Chemical Society, 93, 2325-2327.
102. Lebowitz, P. F., Casey, P. J., Prendergast, G. C., & Thissen, J. A. (1997). Farnesyltransferase inhibitors alter the prenylation and growth-stimulating function of RhoB. Journal of Biological Chemistry, 272, 15591-15594.
103. Whyte, D. B., Kirschmeier, P., Hockenberry, T. N., Nunez-Oliva, I., James, L., Catino, J. J., et al. (1997). K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors. Journal of Biological Chemistry, 272, 14459-14464.
104. Rowell, C. A., Kowalczyk, J. J., Lewis, M. D., & Garcia, A. M. (1997). Direct demonstration of geranylgeranylation and farnesylation of Ki-Ras in vivo. Journal of Biological Chemistry, 272, 14093-14097.
105. Mijimolle, N., Velasco, J., Dubus, P., Guerra, C., Weinbaum, C. A., Casey, P. J., et al. (2005). Protein farnesyltransferase in embryogenesis, adult homeostasis, and tumor development. Cancer Cell, 7, 313-324.
106. Konstantinopoulos, P. A., Karamouzis, M. V., & Papavassiliou, A. G. (2007). Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets. Nature Reviews Drug Discovery, 6, 541-555.
107. Parker, B. S., Argani, P., Cook, B. P., Liangfeng, H., Chartrand, S. D., Zhang, M., et al. (2004). Alterations in vascular gene expression in invasive breast carcinoma. Cancer Research, 64, 7857-7866.
108. Anant, J. S., Desnoyers, L., Machius, M., Demeler, B., Hansen, J. C., Westover, K. D., et al. (1998). Mechanism of Rab geranylgeranylation: formation of the catalytic ternary complex. Biochemistry, 37, 12559-12568.
109. Andres, D. A., Seabra, M. C., Brown, M. S., Armstrong, S. A., Smeland, T. E., Cremers, F. P., et al. (1993). cDNA cloning of component A of Rab geranylgeranyl transferase and demonstration of its role as a Rab escort protein. Cell, 73, 1091-1099.